GAS6 and kidney disorder: Previous studies have shown the controversial effects of Gas6/AXL in several kidney disease models, e.g., anti-Thy-1-induced nephritis, anti-glomerular basement membrane (GBM)-induced nephritis, streptozotocin-induced diabetic nephropathy, and renal ischemia-reperfusion [21–24, 34–37].